University of California, Los Angeles (UCLA), Health Sciences

Surgeon General expects COVID-19 vaccine to be available by year’s end

Dr. Jerome Adams addresses UCLA faculty and staff in Grand Rounds lecture

By Sandy Cohen • October 29, 2020

Newswise — Dr. Jerome Adams addresses UCLA faculty and staff in Grand Rounds lecture. 

In a wide-ranging talk with UCLA Health physicians, Wednesday, Oct. 28, United States Surgeon General Jerome Adams, MD, MPH, addressed the politicization of the pandemic and the means of containing the spread of COVID-19. He also offered hope that a vaccine for the virus will be available by year’s end.

Dr. Adams said he has “a high degree of confidence” in a vaccine’s success. “This is the most scrutinized vaccine of all time,” he said. “The vaccine will be safe and effective because of process, not because of politics.”

Meanwhile, he said the “three Ws” — wearing a mask, washing your hands and watching your distance from others — are the most effective ways to curb transmission of the virus and to keep businesses and schools open.

Dr. Adams’ 50-minute talk, delivered via Zoom, was part of the Department of Anesthesiology and Perioperative Medicine’s Grand Rounds series.

The nation’s 20th surgeon general did not shy away from the intersection between public health and politics in his talk just days before the presidential election. He decried how politicization of the pandemic has contributed to confusion and distrust around measures to contain the virus, from mask-wearing to the development of a vaccine.

Even scientists and others dedicated to public health are not impervious to the effects of bias, Dr. Adams said. “Politics, geography, race and biases creep into the way we think about things.”

He said “pre-existing social conditions” played a major role in the effects of COVID-19 on populations of color, noting that members of the Black community have been hospitalized with the virus at five times the rate of white people.

“Social determinants make individuals more susceptible to COVID-19,” he said.

Social justice and racial inequity were themes throughout Dr. Adams’ presentation. Rates of vaccination against influenza are historically lower among people of color, he said, calling the flu “a social justice issue.” He added that more widespread receptivity to the flu vaccine can make acceptance of an eventual COVID-19 vaccine more likely.

“This is the most important flu season of our lives,” he said to the audience of more than 200 health professionals.

Dr. Adams discussed the mental-health costs of the pandemic, noting the increase in suicides and adding that physicians have higher rates of suicide than the general public. He said he will issue a call-to-action regarding suicide awareness in December.

He also said he would issue, in December, a call-to-action about maternal mortality. Black women are three times more likely than white women to die during pregnancy or childbirth, a reality, he said, that is “one of the most glaring examples of bias, racism and inequity” in health care.

“The health of our nation depends on the health of our mothers,” he said.

Already this year, Dr. Adams has released a call-to-action to increase awareness about the risks of hypertension. He said 500,000 people who die this year will have high blood pressure listed as the primary or secondary cause of death. Hypertension also is correlated with a higher risk of complications from COVID-19, he said, adding that one in two adults – himself included – has high blood pressure.

Concluding his talk on a hopeful note, Dr. Adams said he believes distribution of a COVID-19 vaccine will be fair and equitable. To ensure diversity in this effort, the Department of Health and Human Services commissioned the National Academies of Medicine to design a framework for distributing the vaccine in addition to trial parameters.

“I want you to be encouraged, because we’re almost to a vaccine,” he said. “I want you to be encouraged, because we know much more about who is at risk and why, and we’re, therefore, doing a better job of protecting them.

“We know what works to keep people safe,” Dr. Adams said. “When you look at New York, they were the worst in the world for COVID-19, and they were able to drive their transmission rates down to less than 1%. They didn’t have a vaccine; they did it with the three Ws.”

Filters close

Showing results

110 of 5419
Released: 15-Apr-2021 4:10 PM EDT
Penn Study Suggests Those Who Had COVID-19 May Only Need One Vaccine Dose
Perelman School of Medicine at the University of Pennsylvania

New findings from Penn suggest that people who have recovered from COVID-19 may only need a single mRNA vaccine dose. However, those who did not have COVID-19 did not have a full immune response until after a second vaccine dose, reinforcing the importance of completing the two recommended doses.

Released: 15-Apr-2021 4:00 PM EDT
June 2021 Issue of AJPH Comprises the Effects of COVID-19 on Drug Overdoses, E-cigarette Use, and Public Health Measures and Strategies
American Public Health Association (APHA)

June 2021 AJPH Issue highlights COVID-19 concerns in relation to fatal drug overdoses, drops in youth e-cigarette use, importance of public health measures, and strategies to protect correctional staff.

Newswise: 262150_web.jpg
Released: 15-Apr-2021 3:20 PM EDT
COVID-19 reduces access to opioid dependency treatment for new patients
Princeton University

COVID-19 has been associated with increases in opioid overdose deaths, which may be in part because the pandemic limited access to buprenorphine, a treatment used for opioid dependency, according to a new study led by Princeton University researchers.

Newswise: UGA to Establish National NIH-funded Center to Fight Flu
Released: 15-Apr-2021 2:45 PM EDT
UGA to Establish National NIH-funded Center to Fight Flu
University of Georgia

The National Institutes of Health has awarded the University of Georgia a contract to establish the Center for Influenza Disease and Emergence Research (CIDER). The contract will provide $1 million in first-year funding and is expected to be supported by the National Institute of Allergy and Infectious Diseases (NIAID), part of NIH, for seven years and up to approximately $92 million.

Released: 15-Apr-2021 2:15 PM EDT
Meatpacking plants increased COVID-19 cases in US counties
University of California, Davis

An estimated 334,000 COVID-19 cases are attributable to meatpacking plants, resulting in $11.2 billion in economic damage, according to a new study led by a researcher at the University of California, Davis.

Newswise: 262052_web.jpg
Released: 15-Apr-2021 1:55 PM EDT
How to build a city that prioritizes public health
Colorado State University

Most people by now have memorized the public health guidelines meant to help minimize transmission of COVID-19: wash your hands, wear a mask, keep six feet apart from others. That part is easy.

Released: 15-Apr-2021 1:45 PM EDT
Wake Forest School of Medicine Begins Study to Test New Mask for Healthcare Workers
Wake Forest Baptist Health

Open Standard Industries, Inc. (OSI), manufacturer of the OSR-M1 non-valved reusable elastomeric face mask, is pleased to formally announce the launch of its first Institutional Review Board (IRB)-approved user feasibility study. The trial is being led by the departments of Biomedical Engineering and Infectious Diseases at Wake Forest School of Medicine, part of Wake Forest Baptist Health. Recruitment in the study is underway, and enrollment is expected to be completed by May 28, 2021.

Newswise: Major clinical trial to test Pfizer-BioNTech COVID-19 vaccine opens for enrollment at UTHealth in Houston
Released: 15-Apr-2021 1:45 PM EDT
Major clinical trial to test Pfizer-BioNTech COVID-19 vaccine opens for enrollment at UTHealth in Houston
University of Texas Health Science Center at Houston

A large national clinical trial to evaluate the Pfizer-BioNTech COVID-19 vaccine for safety and efficacy in pregnant women is now open for enrollment at The University of Texas Health Science Center at Houston (UTHealth).

Released: 15-Apr-2021 1:15 PM EDT
For veterans, a hidden side effect of COVID: Feelings of personal growth
Yale University

The U.S. military veteran population is known to have abnormally high rates of suicide, so health officials have been concerned that the COVID-19 pandemic might elevate risk of psychiatric disorders, particularly among those suffering from post-traumatic stress and related disorders.

Newswise: 262026_web.jpg
Released: 15-Apr-2021 12:55 PM EDT
Significant spread of all coronavirus variants tracked in Houston area

In late 2020, several concerning SARS-CoV-2 variants emerged globally. They are believed to be more easily transmissible, and there is concern that some may reduce the effectiveness of antibody treatments and vaccines.

Showing results

110 of 5419